Literature DB >> 12748991

Plasma lipoproteins in transport of silibinin, an antioxidant flavonolignan from Silybum marianum.

Zdenek Svagera1, Nina Skottová, Petr Vána, Rostislav Vecera, Karel Urbánek, Marie Belejová, Pavel Kosina, Vilím Simánek.   

Abstract

To assess the role of plasma lipoproteins in the transport of silibinin, an antioxidant flavonolignan, (125)I-labelled silibinin ((125)I-SB) administered perorally to the rat was used. The plasma (125)I-SB derived radioactivity was distributed among plasma lipoproteins according to their lipophilicity (TAG-rich lipoproteins 30-40% > LDL 15% > HDL 5%), and in the fraction of d > 1.215 containing albumin and other proteins a minority amount of radioactivity was found. Administration of (125)I-SB in a complex with phosphatidylcholine resulted in proportionally higher radioactivities in all fractions as well as in tissues. Dietary olive oil had a slightly decreasing effect on plasma concentrations of silibinin measured by HPLC as well as on (125)I-SB derived radioactivity in plasma and liver. In the TAG-rich lipoprotein fraction and HDL no effects of olive oil on the levels of (125)I-SB derived radioactivities were observed, however, at a 30 min interval the levels of (125)I-SB derived radioactivity in LDL and the heart were significantly decreased in the olive oil group. These results suggest that (i) silibinin is not resorbed by the chylomicron pathway, and (ii) the endogenous lipoprotein pathway VLDL --> LDL may play a role in the transport of silibinin from the liver to the extrahepatic tissues concurrently facilitating the lipoprotein antioxidant influence of silibinin. Copyright 2003 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12748991     DOI: 10.1002/ptr.1187

Source DB:  PubMed          Journal:  Phytother Res        ISSN: 0951-418X            Impact factor:   5.878


  4 in total

1.  Antioxidant, DNA cleavage, and cellular effects of silibinin and a new oxovanadium(IV)/silibinin complex.

Authors:  Luciana G Naso; Evelina G Ferrer; Nataliya Butenko; Isabel Cavaco; Luis Lezama; Teófilo Rojo; Susana B Etcheverry; Patricia A M Williams
Journal:  J Biol Inorg Chem       Date:  2011-03-12       Impact factor: 3.358

2.  Antiproliferative and apoptosis-inducing activity of an oxidovanadium(IV) complex with the flavonoid silibinin against osteosarcoma cells.

Authors:  I E Leon; V Porro; A L Di Virgilio; L G Naso; P A M Williams; M Bollati-Fogolín; S B Etcheverry
Journal:  J Biol Inorg Chem       Date:  2014-01       Impact factor: 3.358

Review 3.  A review of plant-based compounds and medicinal plants effective on atherosclerosis.

Authors:  Mehrnoosh Sedighi; Mahmoud Bahmani; Sedigheh Asgary; Fatemeh Beyranvand; Mahmoud Rafieian-Kopaei
Journal:  J Res Med Sci       Date:  2017-03-15       Impact factor: 1.852

Review 4.  Flavonoids as Therapeutic Agents in Alzheimer's and Parkinson's Diseases: A Systematic Review of Preclinical Evidences.

Authors:  Roxana Braga de Andrade Teles; Tâmara Coimbra Diniz; Tiago Coimbra Costa Pinto; Raimundo Gonçalves de Oliveira Júnior; Mariana Gama E Silva; Érica Martins de Lavor; Antonio Wilton Cavalcante Fernandes; Ana Paula de Oliveira; Fernanda Pires Rodrigues de Almeida Ribeiro; Amanda Alves Marcelino da Silva; Taisy Cinthia Ferro Cavalcante; Lucindo José Quintans Júnior; Jackson Roberto Guedes da Silva Almeida
Journal:  Oxid Med Cell Longev       Date:  2018-05-10       Impact factor: 6.543

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.